See also this year's filing and all EDGAR filings for this company.
PDF Report 0001348362_2019_Lexaria_Bioscience_Corp.pdf
Logs
| warning | The stock_price does not exist | industry.us_generic | {} |
| info | NetIncome node detected by revenue/expenses heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {'net_inc_node': 'IncomeLossFromContinuingOperations'} |
Graph
Absolute values for 0001348362, Lexaria Bioscience Corp
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,284,051 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,237 |
| 3 | remainder_Assets | 146,538 |
| 4 | LiabilitiesCurrent | 43,640 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 993 |
| 8 | SellingGeneralAndAdministrativeExpense | 510,622 |
| 9 | ResearchAndDevelopmentExpense | 434,321 |
| 10 | remainder_Expenses | 15,574,899 |
| 11 | remainder_Revenues | 2,276,913 |
| 12 | remainder_NetIncome | 0 |
| 13 | remainder_ComprehensiveNetIncome | -14,246 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,431,826 |
| 1 | Liabilities | 43,640 |
| 2 | Expenses | 16,520,835 |
| 3 | Revenues | 2,276,913 |
| 4 | StockholdersEquity | 2,388,186 |
| 5 | NetIncome | -14,243,922 |
| 6 | ComprehensiveNetIncome | -14,251,045 |
| 7 | BaseVar | 10,643,730 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -7.31 |
| 9 | EconomicCapitalRatio | 0.0197 |
Edgar->Model Mapping
Feature Distribution
Change over Time
